Simple urine test could spare cancer patients unnecessary treatment
NCT ID NCT07252297
Summary
This study is looking at whether a new urine test can predict if early-stage bladder cancer will return after surgery. Researchers will analyze urine samples from 177 patients to see if a specific genetic marker, called SIX6, is linked to cancer recurrence. The goal is to help doctors better decide which patients need extra treatment after surgery and which can be safely monitored, potentially avoiding overtreatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON MUSCLE INVASIVE BLADDER CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Xi Jing Hopspital
Xi'an, ShannxI, 710300, China
Conditions
Explore the condition pages connected to this study.